Navigation Links
Master Stem Cell for Human Heart Identified
Date:7/1/2009

Researchers say it may hold key to understanding how to repair the organ

WEDNESDAY, July 1 (HealthDay News) -- For the first time, researchers have identified a single "master" stem cell in humans that is capable of differentiating into all three major cell types that make up the human heart.

"This is a very simple but very important and fundamental finding, and that is understanding how the human heart is built, how it is made, what are the progenitor cells which give rise to the human heart," said Dr. Kenneth Chien, head of the Harvard Stem Cell Institute's cardiovascular disease program and senior author of a paper in the July 2 issue of Nature.

"This means we are in a new era where we can envision entirely human-based models of cardiovascular disease," added Chien, who is also director of the Massachusetts General Hospital Cardiovascular Research Center.

Because this is a first, there could be enormous implications for further research into the human heart and, eventually, into repair and regeneration of the organ in people who have had heart attacks or have heart failure or congenital heart defects.

Understanding the mechanisms of the human heart might also help in the development of drugs with fewer heart-related side effects as well as allow better monitoring of drugs already available. Chien, who spoke to journalists in teleconference Wednesday, pointed out that many widely used and valuable drugs, such as Herceptin (for cancer) and Avandia (for diabetes), have heart-related side effects. The painkiller Vioxx was withdrawn from the market after widely publicized side effects were noted.

The breakthrough research "offers more understanding of how to model the development of the human heart, and, by understanding that, we might be able to understand what goes wrong," said Paul Sanberg, a stem cell expert and director of the University of South Florida Center for Aging and Brain Repair in Tampa. "One day there may even be the potential for stem cell therapy."

Although the genesis of the heart has been studied extensively in organisms including zebra fish, flies and mice, much less is known about what happens in the human heart, Chien said.

And while stem cells have been used to treat people after a heart attack, for instance, cells that are used are not from the heart and it's not yet clear how effective the approach really is.

Chien and his team used antibodies directed against islet progenitor cells in human fetal hearts to identify the presence of the cells. They then purified the cells, cloned them and tracked their journey from single stem cell to the three major lineages of heart cells -- smooth muscle, cardiomyocyte muscle and endothelial cells.

Chien said that he thought it would be "entirely unlikely" that scientists would be able to use these cells to "grow" a whole heart.

Instead, the key seems to be in identifying intermediary points and pathways by which the cells branch off into very specific types of cells and subsets of the major cells so they could be directed to these specific destinations.

"This sets up a system where we can now use scientific tools to rigorously identify the pathways that would drive the cell to become the cell of interest and not become the other cell of interest, and to test each rigorously in animal models as to which one would have a therapeutic effect," Chien said.

The researchers suspect that defects in the decisions of these stem cells could be responsible for various types of congenital heart disease.

But there is a danger in using embryonic stem cells in humans, according to Dr. Darwin J. Prockop, director of the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White. And that is the potential for the cells to form tumors down the line.

"How can you be sure that a few cells that are left aren't immortal and tumorgenic?" he asked.

But Chien said he thought both embryonic stem cells and induced pluripotent cells, which are coaxed from adult cells, both have potential.

More information

The U.S. National Institutes of Health have more on stem cells.



SOURCES: Paul Sanberg, Ph.D., D.Sc., distinguished professor of neurosurgery and director, University of South Florida Center for Aging and Brain Repair, Tampa, Fla.; Darwin J. Prockop, M.D., Ph.D., director, Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White, Temple, Texas; July 1, 2009, teleconference with Kenneth Chien, M.D., Ph.D., head, cardiovascular disease program, Harvard Stem Cell Institute, and director, Massachusetts General Hospital Cardiovascular Research Center, Boston; July 2, 2009, Nature


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
2. RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact
3. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
4. Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development
5. Nursing Scholarships Offered by Western Governors University for Masters Degree Programs
6. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
7. LifeMasters Receives Full URAC Disease Management Accreditation
8. McMaster test detects the most prevalent respiratory viruses
9. The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida
10. Special Masters Appointed in Program to Resolve U.S. VIOXX(R) Product Liability Lawsuits
11. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Master Stem Cell for Human Heart Identified
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017   Divoti USA will ... to the standard of the latest FDA requirements, which stipulates new ... Anyone in need of Medical ID jewelry such as Medical ... are engraved in terms of the new FDA requirements ... Divoti offers this dark ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
Breaking Medicine Technology: